Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange May 27, 2021
Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative Drug Development… May 26, 2021
MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing May 26, 2021
Wake Network Just Conducted The First Legal Import of Psilocybin To The U.S. From Jamaica May 21, 2021
Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd May 20, 2021
Cybin Files its 12th Patent Further Strengthening IP Portfolio of Novel Psychedelic Molecules and Delivery Mechanisms May 20, 2021
Dr. Joel Raskin, a leader in psychiatry and neuroscience drug development, joins MINDCURE as Chief Medical Officer May 20, 2021
